Puma Net Interest Income from 2010 to 2024
| PBYI Stock | USD 5.02 0.14 2.87% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -2.6 M | Current Value -2.6 M | Quarterly Volatility 438.6 K |
Check Puma Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Puma main balance sheet or income statement drivers, such as Interest Expense of 14 M, Other Operating Expenses of 174.6 M or Operating Income of 34.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 3.63. Puma financial statements analysis is a perfect complement when working with Puma Biotechnology Valuation or Volatility modules.
Puma | Net Interest Income |
Latest Puma Biotechnology's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Puma Biotechnology over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Puma Biotechnology's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Puma Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Puma Net Interest Income Regression Statistics
| Arithmetic Mean | (4,892,500) | |
| Coefficient Of Variation | (132.56) | |
| Mean Deviation | 6,184,267 | |
| Median | 536,000 | |
| Standard Deviation | 6,485,498 | |
| Sample Variance | 42.1T | |
| Range | 14.6M | |
| R-Value | (0.86) | |
| Mean Square Error | 11.5T | |
| R-Squared | 0.75 | |
| Significance | 0.000034 | |
| Slope | (1,251,741) | |
| Total Sum of Squares | 588.9T |
Puma Net Interest Income History
About Puma Biotechnology Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Puma Biotechnology income statement, its balance sheet, and the statement of cash flows. Puma Biotechnology investors use historical funamental indicators, such as Puma Biotechnology's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Puma Biotechnology investors may use each financial statement separately, they are all related. The changes in Puma Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Puma Biotechnology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Puma Biotechnology Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Puma Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -10.8 M | -11.4 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Puma Biotechnology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Puma Biotechnology Correlation against competitors. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share 0.45 | Revenue Per Share 4.999 | Quarterly Revenue Growth 0.099 | Return On Assets 0.0919 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.